Basilix Cert (BAS) | Financial Analysis & Statements

Basilix Cert | Small-cap | Real Estate

€27.80

0.00%

Basilix Cert vs Syneos Health Basilix Cert vs Solvay SA Basilix Cert vs Anheuser-Busch InBev Basilix Cert vs Azelis Group NV Basilix Cert vs Titan Cement Basilix Cert vs BEL 20 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0

Gross Profit -169.0K

Operating Income -170.8K

Net Income 465.9K

Balance Sheet Metrics

Total Assets 4.2M

Total Liabilities 4.1M

Shareholders Equity 67.0K

Debt to Equity 61.62

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Basilix Cert Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	0	0	0	0	0
Cost of Goods Sold	169.0K	58.7K	84.7K	67.6K	40.0K
Gross Profit	-169.0K	-58.7K	-84.7K	-67.6K	-40.0K
Operating Expenses	1.7K	868	1.3K	48.6K	868
Operating Income	-170.8K	-59.6K	-86.0K	-116.2K	-40.9K
Pre-tax Income	465.9K	-19.4K	-103.0K	-83.2K	-55.7K
Income Tax	-	-	-	-	-
Net Income	465.9K	-19.4K	-103.0K	-83.2K	-55.7K
EPS (Diluted)	-	-	-	-	-

Income Statement Trend

Basilix Cert Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	4.2M	2.3M	2.3M	2.4M	2.5M
Non-Current Assets	0	0	0	0	0
Total Assets	4.2M	2.3M	2.3M	2.4M	2.5M
Liabilities
Current Liabilities	4.1M	981.9K	1.0M	983.8K	1.0M
Non-Current Liabilities	0	1.7M	1.7M	1.7M	1.7M
Total Liabilities	4.1M	2.7M	2.7M	2.7M	2.7M
Equity
Total Shareholders Equity	67.0K	-398.9K	-379.5K	-276.5K	-193.3K

Balance Sheet Composition

Basilix Cert Cash Flow Statement

No cash flow data available.

Basilix Cert Key Financial Ratios

Valuation Ratios

Profitability Ratios

Profit Margin 0.00%

Operating Margin 0.00%

Return on Equity 695.33%

Return on Assets -2.28%

Financial Health

Current Ratio 74.37

Debt to Equity 25.22

Beta 1.11

Per Share Data

EPS (TTM) -€1.42

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
bas	3.7M	-	-	695.33%	0.00%	25.22
Syneos Health	6.9B	377.86	1.03	-1.38%	-1.59%	28.51
Solvay SA	3.1B	15.83	2.26	14.16%	3.88%	155.68
Anheuser-Busch InBev	120.4B	21.06	1.57	6.60%	11.75%	81.53
Azelis Group NV	3.2B	17.86	1.12	6.77%	4.29%	63.15
Titan Cement	2.9B	9.97	1.41	15.09%	10.55%	33.45

Financial data is updated regularly. All figures are in the company's reporting currency.